Three NIH institutes and the U.S. Food and Drug Administration are offering funding to establish research centers that will accelerate the translational use of microphysiological systems (MPS) in drug development through regulatory acceptance and adoption for industrial use. The envisioned centers will support development of MPS that are fit-for-purpose for industry needs, have defined contexts-of-use, and will be developed with consideration of applicable expectations to achieve regulatory approval. These centers will further the development of MPS as drug development tools that, once qualified, will be made publicly and commercially available to fill unmet needs in drug development. U.S.-based nonprofit and for-profit institutions are encouraged to apply for funding; foreign institutions are not eligible. Applications will be accepted beginning February 27 and are due by March 28. For more information visit

A pre-application technical assistance webinar for this funding opportunity will be presented Tuesday, January 24, at 3:00 p.m. EST. Register for the webinar by sending an email to by Tuesday, January 17. More information about the webinar is available at